Zahra Jahanshiri
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zahra Jahanshiri has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
Farahnaz Hatami
Department of Mycology, Pasteur Institute of Iran, Tehran, Iran
4 shared publications- Mehdi Razzaghi-Abyaneh
Department of Mycology, Pasteur Institute of Iran, Tehran, Iran
4 shared publications Soheila Manifar
Department of Oral Medicine, School of Dentistry, Tehran University of Medical Sciences, Cancer Institute of Tehran, Imam Khomeini Hospital Complex, Tehran, Iran
3 shared publicationsFarnoush Asghari-Paskiabi
Department of Mycology, Pasteur Institute of Iran, Tehran, Iran
2 shared publications- Masoomeh Shams-Ghahfarokhi
Department of Mycology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
2 shared publications Sima-Sadat Seyedjavadi
Department of Mycology, Pasteur Institute of Iran, Tehran, Iran
2 shared publications
Latest Publications
- Open Access
- 28 October 2026
- Published by Springer Nature in AMB Express
Efficacy of cold atmospheric plasma and fluconazole against resistant Candida species in oropharyngeal candidiasis patients
- 28 October 2026
- Published by Springer Nature in AMB Express
Open AccessEfficacy of cold atmospheric plasma and fluconazole against resistant Candida species in oropharyngeal candidiasis patients
- Open Access
- 1 August 2026
- Published by Taylor & Francis in Drug Design, Development and Therapy
- Vol. ume 20, 1-16
Rational Design and Optimization of MCh-AMP1: A Stable α-Helical Antifungal Peptide with Enhanced Activity Against Candida albicans
- 1 August 2026
- Published by Taylor & Francis in Drug Design, Development and Therapy
- Vol. ume 20, 1-16
Open AccessRational Design and Optimization of MCh-AMP1: A Stable α-Helical Antifungal Peptide with Enhanced Activity Against Candida albicans
- Open Access
- 8 July 2026
- Published by Springer Nature in AMB Express
- Vol. 16 (1)
Combination antifungal therapy against resistant C. albicans: efficacy and immune response in mice
This study demonstrates the therapeutic effects of combination therapies against Candida albicans in mouse models, as opposed to mono-therapeutic treatment
- 8 July 2026
- Published by Springer Nature in AMB Express
- Vol. 16 (1)
Open AccessCombination antifungal therapy against resistant C. albicans: efficacy and immune response in mice
This study demonstrates the therapeutic effects of combination therapies against Candida albicans in mouse models, as opposed to mono-therapeutic treatment
- Open Access
- 19 February 2026
- Published by Pensoft Publishers in IMA Fungus
- Vol. 17
Dermatophytosis in Iran: a sharp increase in cases caused by Trichophyton mentagrophytes var. indotineae
Dermatophytosis is a common skin infection worldwide. In recent years, Trichophyton mentagrophytes var. indotineae has rapidly emerged as a leading cause of recalcitrant dermatophytosis. Iran shows high genetic diversity within the T. mentagrophytes complex, suggesting local emergence of new genotypes, yet nationwide data remain limited. We performed a one-year multicentre, hospital-based survey of referred cases (September 2023–September 2024) in nine provinces of Iran to describe the current epidemiology of dermatophytosis and to analyse mutations in the squalene epoxidase (SQLE) gene associated with terbinafine (TRB) resistance. Clinical samples were obtained from 2211 patients with suspected dermatophytosis. Dermatophytes were recovered from 1568 samples (71%). Species-specific PCR identified T. mentagrophytes var. indotineae in 1191 cases (76%), confirming it as the dominant agent across all clinical forms, age groups and provinces. The remaining isolates comprised other dermatophytes, mainly other members of the T. mentagrophytes complex, T. tonsurans and Microsporum canis . Trichophyton mentagrophytes var. indotineae caused most cases of tinea cruris, tinea corporis, mixed infections and generalised dermatophytosis. It also accounted for 59% of tinea unguium and 37% of tinea capitis cases. No significant sex bias was observed and most patients were 20–49 years old. The data did not indicate recent introduction of the infection from outside Iran, supporting ongoing local transmission. SQLE sequencing of 410 isolates revealed resistance-associated mutations in 45% of strains, mainly F397L (72%) and L393S (28%), with the highest frequencies in southern provinces. ITS sequencing of a subset of isolates confirmed their identity as T. indotineae and revealed two ITS genotypes, including a dominant genotype VIII and a new sub-genotype XXIX. These findings show that T. indotineae is now the dominant dermatophyte in Iran and carries a substantial burden of SQLE mutations, highlighting the urgent need for continued molecular surveillance and antifungal stewardship.
- 19 February 2026
- Published by Pensoft Publishers in IMA Fungus
- Vol. 17
Open AccessDermatophytosis in Iran: a sharp increase in cases caused by Trichophyton mentagrophytes var. indotineae
Dermatophytosis is a common skin infection worldwide. In recent years, Trichophyton mentagrophytes var. indotineae has rapidly emerged as a leading cause of recalcitrant dermatophytosis. Iran shows high genetic diversity within the T. mentagrophytes complex, suggesting local emergence of new genotypes, yet nationwide data remain limited. We performed a one-year multicentre, hospital-based survey of referred cases (September 2023–September 2024) in nine provinces of Iran to describe the current epidemiology of dermatophytosis and to analyse mutations in the squalene epoxidase (SQLE) gene associated with terbinafine (TRB) resistance. Clinical samples were obtained from 2211 patients with suspected dermatophytosis. Dermatophytes were recovered from 1568 samples (71%). Species-specific PCR identified T. mentagrophytes var. indotineae in 1191 cases (76%), confirming it as the dominant agent across all clinical forms, age groups and provinces. The remaining isolates comprised other dermatophytes, mainly other members of the T. mentagrophytes complex, T. tonsurans and Microsporum canis . Trichophyton mentagrophytes var. indotineae caused most cases of tinea cruris, tinea corporis, mixed infections and generalised dermatophytosis. It also accounted for 59% of tinea unguium and 37% of tinea capitis cases. No significant sex bias was observed and most patients were 20–49 years old. The data did not indicate recent introduction of the infection from outside Iran, supporting ongoing local transmission. SQLE sequencing of 410 isolates revealed resistance-associated mutations in 45% of strains, mainly F397L (72%) and L393S (28%), with the highest frequencies in southern provinces. ITS sequencing of a subset of isolates confirmed their identity as T. indotineae and revealed two ITS genotypes, including a dominant genotype VIII and a new sub-genotype XXIX. These findings show that T. indotineae is now the dominant dermatophyte in Iran and carries a substantial burden of SQLE mutations, highlighting the urgent need for continued molecular surveillance and antifungal stewardship.
- Open Access
- 1 December 2025
- Published by InkVista Publishing House in Journal of Medical Microbiology and Infectious Diseases
- Vol. 13 (4) , 303-309
Effects of Capsaicin on the Growth and Virulence Factors of Aspergillus fumigatus
- 1 December 2025
- Published by InkVista Publishing House in Journal of Medical Microbiology and Infectious Diseases
- Vol. 13 (4) , 303-309
Open AccessEffects of Capsaicin on the Growth and Virulence Factors of Aspergillus fumigatus
- Open Access
- 1 May 2025
- Published by National Academy of Sciences of Tajikistan
- Vol. 29 (3) , 126-137
Antifungal Potential of Streptomyces-Derived Metabolites Against Fluconazole-Resistant Oral Candida albicans: In vitro Evaluation and Mechanistic Insights
Background: Oropharyngeal candidiasis, primarily caused by Candida albicans, is the most common opportunistic fungal infection in patients with head and neck cancer. The increasing emergence of fluconazole (FLZ) resistance has led to higher morbidity and mortality rates. Streptomyces, a genus of Actinomycetes, produces bioactive molecules with antimicrobial effects. This study investigated the ...
- 1 May 2025
- Published by National Academy of Sciences of Tajikistan
- Vol. 29 (3) , 126-137
Open AccessAntifungal Potential of Streptomyces-Derived Metabolites Against Fluconazole-Resistant Oral Candida albicans: In vitro Evaluation and Mechanistic Insights
Background: Oropharyngeal candidiasis, primarily caused by Candida albicans, is the most common opportunistic fungal infection in patients with head and neck cancer. The increasing emergence of fluconazole (FLZ) resistance has led to higher morbidity and mortality rates. Streptomyces, a genus of Actinomycetes, produces bioactive molecules with antimicrobial effects. This study investigated the ...
- Open Access
- 1 March 2024
- Published by Apex Publishing in Journal of Medical Microbiology and Infectious Diseases
- Vol. 12 (1) , 1-21
Nanotechnology-Based Strategies for Combating Emerging and Re-emerging Fungal Infections
The emergence and re-emergence of pathogenic fungi pose a significant challenge, fueled by factors like increased immunosuppression and climate changes. Despite the development of new antifungal drugs and therapies, controlling these infections remains a pressing issue. Candida auris, a multidrug-resistant yeast, has caused invasive infections with high mortality rates in hospitals worldwide, with ...
- 1 March 2024
- Published by Apex Publishing in Journal of Medical Microbiology and Infectious Diseases
- Vol. 12 (1) , 1-21
Open AccessNanotechnology-Based Strategies for Combating Emerging and Re-emerging Fungal Infections
The emergence and re-emergence of pathogenic fungi pose a significant challenge, fueled by factors like increased immunosuppression and climate changes. Despite the development of new antifungal drugs and therapies, controlling these infections remains a pressing issue. Candida auris, a multidrug-resistant yeast, has caused invasive infections with high mortality rates in hospitals worldwide, with ...
- 1 July 2023
- Published by Elsevier in Archives of Oral Biology
- Vol. 154, 105757
Molecular mechanisms of azole resistance in Candida glabrata isolated from oropharyngeal candidiasis in head and neck cancer patients
- 1 July 2023
- Published by Elsevier in Archives of Oral Biology
- Vol. 154, 105757
Molecular mechanisms of azole resistance in Candida glabrata isolated from oropharyngeal candidiasis in head and neck cancer patients
- Open Access
- 13 February 2023
- Published by Knowledge E DMCC in Iranian Journal of Microbiology
- Vol. 15 (1) , 163-173
Evaluation of virulence factors and azole resistance mechanisms of Candida tropicalis isolates from head and neck cancer patients with OPC
Background and Objectives: Candida tropicalis is one of the major non-albicans species causing nosocomial infection. There is limited data about mechanisms of azole-resistance and virulence factors of Candida tropicalis. This study was designed to investigate molecular mechanism of azole -resistance and major virulence factors of C. tropicalis isolated from oropharyngeal candidiasis in head and neck cancer patients. Materials and Methods: After collecting 38 C. tropicalis clinical isolates, antifungal susceptibility pattern and the expression levels of ERG11, CDR1, CDR2 and MDR1 were evaluated. Moreover, proteinase and phospholipase activity and biofilm formation of the isolates were investigated as virulence factors. Results: We detected fluconazole resistance in 7 C. tropicalis isolates. The expression levels of CDR1, ERG11 and MDR1 were increased respectively. Protease activity and biofilm formation were seen in all isolates. Five isolates did not exhibit phospholipase activity. Conclusion: Taken together, the overexpressions of ERG11, CDR1 and MDR1 genes were found in fluconazole resistant C. tropicalis, isolated from oropharyngeal candidiasis patients. Also, voriconazole was an effective antifungal against C. tropicalis isolates. The observed high protease enzyme activity and biofilm formation suggested strong pathogenicity of these isolates.
- 13 February 2023
- Published by Knowledge E DMCC in Iranian Journal of Microbiology
- Vol. 15 (1) , 163-173
Open AccessEvaluation of virulence factors and azole resistance mechanisms of Candida tropicalis isolates from head and neck cancer patients with OPC
Background and Objectives: Candida tropicalis is one of the major non-albicans species causing nosocomial infection. There is limited data about mechanisms of azole-resistance and virulence factors of Candida tropicalis. This study was designed to investigate molecular mechanism of azole -resistance and major virulence factors of C. tropicalis isolated from oropharyngeal candidiasis in head and neck cancer patients. Materials and Methods: After collecting 38 C. tropicalis clinical isolates, antifungal susceptibility pattern and the expression levels of ERG11, CDR1, CDR2 and MDR1 were evaluated. Moreover, proteinase and phospholipase activity and biofilm formation of the isolates were investigated as virulence factors. Results: We detected fluconazole resistance in 7 C. tropicalis isolates. The expression levels of CDR1, ERG11 and MDR1 were increased respectively. Protease activity and biofilm formation were seen in all isolates. Five isolates did not exhibit phospholipase activity. Conclusion: Taken together, the overexpressions of ERG11, CDR1 and MDR1 genes were found in fluconazole resistant C. tropicalis, isolated from oropharyngeal candidiasis patients. Also, voriconazole was an effective antifungal against C. tropicalis isolates. The observed high protease enzyme activity and biofilm formation suggested strong pathogenicity of these isolates.
- Open Access
- 13 November 2022
- Published by Brieflands in Jundishapur Journal of Microbiology
- Vol. 15 (9)
Azole Resistance in Candida albicans Isolates from Oropharyngeal Candidiasis is Associated with ERG11 Mutation and Efflux Overexpression
Background: Azole resistance rates are rising in Candida species. Fluconazole is one of the most important antifungal drugs used in candidiasis treatment. Objectives: We identified the molecular mechanisms of fluconazole resistance of Candida albicans oropharyngeal candidiasis (OPC) isolates obtained from head and neck cancer patients, a study carried out between 2018 and 2020. Methods: One hundred and twenty-five C. albicans clinical isolates were collected. Antifungal susceptibilities were determined by the CLSI- M27-A3 method. The ERG11 gene was amplified and sequenced to discover SNP mutation. Moreover, real-time PCR was carried out to measure the mRNA levels of ERG11, CDR1, CDR2, and MDR1. Results: Resistance to fluconazole was found in 15 C. albicans isolates. Amino acid substitutions E266D and D116E were observed in resistant, sensitive dose-dependent (SDD), and susceptible C. albicans isolates. K128T, G465S, A114S, Y257H and V488I were in relation to fluconazole resistance. D504A, P375A, W520C, G59S, and V51L were novel substitutions detected in the isolates; except for D504A, other mutations were observed only in resistance isolates. The expression levels of CDR2, CDR1, MDR1, and ERG11 were increased compared to susceptible isolates, respectively. Conclusions: ERG11 mutation was the principal mechanism for fluconazole resistance in C. albicans isolated from oropharyngeal candidiasis patients, and caspofungin can be used as the effective antifungal substance in fluconazole resistance situation for C. albicans infection.
- 13 November 2022
- Published by Brieflands in Jundishapur Journal of Microbiology
- Vol. 15 (9)
Open AccessAzole Resistance in Candida albicans Isolates from Oropharyngeal Candidiasis is Associated with ERG11 Mutation and Efflux Overexpression
Background: Azole resistance rates are rising in Candida species. Fluconazole is one of the most important antifungal drugs used in candidiasis treatment. Objectives: We identified the molecular mechanisms of fluconazole resistance of Candida albicans oropharyngeal candidiasis (OPC) isolates obtained from head and neck cancer patients, a study carried out between 2018 and 2020. Methods: One hundred and twenty-five C. albicans clinical isolates were collected. Antifungal susceptibilities were determined by the CLSI- M27-A3 method. The ERG11 gene was amplified and sequenced to discover SNP mutation. Moreover, real-time PCR was carried out to measure the mRNA levels of ERG11, CDR1, CDR2, and MDR1. Results: Resistance to fluconazole was found in 15 C. albicans isolates. Amino acid substitutions E266D and D116E were observed in resistant, sensitive dose-dependent (SDD), and susceptible C. albicans isolates. K128T, G465S, A114S, Y257H and V488I were in relation to fluconazole resistance. D504A, P375A, W520C, G59S, and V51L were novel substitutions detected in the isolates; except for D504A, other mutations were observed only in resistance isolates. The expression levels of CDR2, CDR1, MDR1, and ERG11 were increased compared to susceptible isolates, respectively. Conclusions: ERG11 mutation was the principal mechanism for fluconazole resistance in C. albicans isolated from oropharyngeal candidiasis patients, and caspofungin can be used as the effective antifungal substance in fluconazole resistance situation for C. albicans infection.